Irreversible EGFR Inhibitor EKB-569 Targets Low-LET γ-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma

EKB-569 (Pelitinib), an irreversible EGFR tyrosine kinase inhibitor has shown potential therapeutic efficiency in solid tumors. However, cell-killing potential in combination with radiotherapy and its underlying molecular orchestration remain to be explored. The objective of this study was to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravindan, Natarajan, Thomas, Charles R., Aravindan, Sheeja, Mohan, Aswathi S., Veeraraghavan, Jamunarani, Natarajan, Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248439/
https://www.ncbi.nlm.nih.gov/pubmed/22242139
http://dx.doi.org/10.1371/journal.pone.0029705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248439/
https://www.ncbi.nlm.nih.gov/pubmed/22242139
http://dx.doi.org/10.1371/journal.pone.0029705

Ejemplares similares